JP2024507550A5 - - Google Patents
Info
- Publication number
- JP2024507550A5 JP2024507550A5 JP2023550695A JP2023550695A JP2024507550A5 JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5 JP 2023550695 A JP2023550695 A JP 2023550695A JP 2023550695 A JP2023550695 A JP 2023550695A JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- compound according
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163152356P | 2021-02-23 | 2021-02-23 | |
| US63/152,356 | 2021-02-23 | ||
| PCT/US2022/017134 WO2022182604A1 (en) | 2021-02-23 | 2022-02-21 | Compounds useful in hiv treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507550A JP2024507550A (ja) | 2024-02-20 |
| JP2024507550A5 true JP2024507550A5 (cg-RX-API-DMAC7.html) | 2025-03-05 |
Family
ID=80685329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023550695A Withdrawn JP2024507550A (ja) | 2021-02-23 | 2022-02-21 | Ｈｉｖ療法に有用な化合物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240182510A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4298105A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024507550A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022182604A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4358968A4 (en) * | 2021-06-22 | 2025-05-07 | Rome Therapeutics, Inc. | 4-ETHINYL-3-HYDROXY-TETRAHYDROFURANYL ADENINE PHOSPHORAMIDATE AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| EP1378509A4 (en) | 2001-03-19 | 2009-03-25 | Ono Pharmaceutical Co | DRUGS WITH TRIAZASPIRO ç5.5] UNDECANDERIVATES AS ACTIVE SUBSTANCE |
| CA2502109C (en) | 2004-03-24 | 2010-02-23 | Yamasa Corporation | 4'-c-substituted-2-haloadenosine derivative |
| CN104640444B (zh) * | 2012-06-16 | 2016-12-14 | 河南美泰宝生物制药有限公司 | 双肝脏靶向氨基磷酸酯和氨基膦酸酯前药 |
| CN113811360A (zh) * | 2019-03-06 | 2021-12-17 | 葛兰素史密斯克莱知识产权（第2 号）有限公司 | 用于hiv治疗的化合物 |
| WO2021188959A1 (en) * | 2020-03-20 | 2021-09-23 | Gilead Sciences, Inc. | Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same |
-
2022
- 2022-02-21 WO PCT/US2022/017134 patent/WO2022182604A1/en not_active Ceased
- 2022-02-21 JP JP2023550695A patent/JP2024507550A/ja not_active Withdrawn
- 2022-02-21 US US18/547,001 patent/US20240182510A1/en active Pending
- 2022-02-21 EP EP22709474.5A patent/EP4298105A1/en active Pending